drugset / Trial / NCT03362853

A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic Characteristics

NCT03362853

Phase 1 Completed 48 enrolled TaiGen Biotechnology Co., Ltd.
RandomizedCrossoverQuadruple-blindTreatment

Summary

A randomized, single-center, placebo and positive control, 4-period and 4-crossover clinical study with the following main purposes: (1) To evaluate the effect of a single-dose oral administration of nemonoxacin malate capsule on QTc intervals and heart rhythms of healthy subjects. (2) To evaluate the influence of food intake on QTc intervals and pharmacokinetic characteristics.

Timeline

Start
2012-06-25
Primary completion
2012-08-10
Completion
2012-08-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Moxifloxacin Small molecule 400 mg Oral
Subject Nemonoxacin Small molecule 500 mg Oral
Subject Nemonoxacin Small molecule 750 mg Oral

Indications

No indication recorded.